Alphamab Oncology Discloses Share Repurchase in HKEX Next Day ReturnPUBT·Nov 16, 2026 at 01:59 PM09966-2.74%
Alphamab Oncology Appoints David Ng as Chief Financial OfficerPUBT·Nov 12, 2026 at 12:02 AM09966-2.74%
Alphamab Oncology Files Next Day Disclosure Return With HKEX Announcing Share BuybackPUBT·Nov 11, 2026 at 10:52 AM09966-2.74%
Alphamab Oncology Reports Share Buyback in HKEX Next Day Disclosure ReturnPUBT·Nov 5, 2026 at 11:19 AM09966-2.74%
Alphamab climbs 7% as FDA clears JSKN021 for clinical trialsMarket Movers·Nov 4, 2026 at 01:38 AM09966-2.74%
Alphamab Oncology Discloses Share Buyback in HKEX Next Day ReturnPUBT·Nov 3, 2026 at 12:48 PM09966-2.74%
Alphamab Oncology Files Next-Day Disclosure With HKEX Announcing Share BuybackPUBT·Nov 2, 2026 at 11:46 AM09966-2.74%
Alphamab Oncology Doses First Patient in Phase III Cervical Cancer Trial of JSKN033PUBT·Oct 28, 2026 at 12:56 PM09966-2.74%